Studies have found that ICAM-1 is overexpressed in different types of cancer13, including thyroid cancer, and has associated it with aggressive features such as extrathyroidal extension, lymph node metastasis, and BRAFV600E mutation14–16. Here, ICAM1 is linked to thyroid cancer.